A H Beckett’s research while affiliated with University of London and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (258)


In-vitro metabolism of two mono-substituted piperazines using liver homogenates of rats and rabbits
  • Article

October 1983

·

9 Reads

·

3 Citations

Journal of Pharmacy and Pharmacology

·

A H Beckett

Buccal uptake, urinary excretion, and physicochemical properties of zipeprol and its N-dealkylated products

July 1982

·

6 Reads

·

7 Citations

Biopharmaceutics & Drug Disposition

Buccal uptake, partition characteristics, ionization constants, and urinary excretion were studied for zipeprol and two of its metabolites. Buccal uptake, measured in a single subject, was found to be correlated with n-heptane/water (ph 7.4) partition values of the compounds, and with proportional excretion of the unchanged drug. The importance of the shape of buccal uptake-pH curves in the prediction of absorption and excretion of these compounds is discussed.



Use and abuse of drugs in sport

February 1981

·

13 Reads

·

9 Citations

Journal of biosocial science. Supplement

An account is presented of the increasing use of drugs in sport, the attempts to test for and control the drugs used, and the devices used to evade detection. The author's view is that all the drugs being used at present can be detected, provided that sufficient funds are available for organizing tests and that national federations co-operate fully.


Synthesis of Some Metabolites of Promethazine

January 1981

·

43 Reads

·

6 Citations

Archiv der Pharmazie

The synthesis of the N-methylnitrone 11, N-monoalkylhydroxylamine 9, N,N-dialkylhydroxylamine 10, Oxime 8 and other potential metabolites of promethazine (1) and of its N-dealkyl derivatives 2,3 are described. Synthese einiger Metabolite von Promethazin Über die Synthese des N-Methylnitrons 11, N-Monoalkylhydroxylamins 9, N,N-Dialkylhydroxylamins 10, Oxims 8 und anderer potentieller Metabolite von Promethazin (1) und seiner N-desalkylierten Derivate wird berichtet.


The acetylcholinesterase inhibitory activity of metoclopramide and some of its biotransformation products

December 1980

·

21 Reads

·

4 Citations

Pharmacy World & Science

Ki values were determined for thein vitro acetylcholinesterase inhibitory activity of the anti-emetic metoclopramide, some of its metabolic products and the newly synthesised N-(ethyl)-4-chlorobenzamide (1). Metoclopramide was a moderate inhibitor, 113 times more potent than 1 and 50 times less potent than physostigmine. Metabolic products of N-de-ethylation, N-di-de-ethylation, deamination followed by reduction and amide hydrolysis were increasingly less active as inhibitors. The implications of the present findings are briefly discussed.


Physicochemical aspects of metabolically induced changes at the basic centre of two anti-emetics; relationship with in vivo membrane penetration

December 1980

·

4 Reads

·

2 Citations

Pharmacy World & Science

Partition coefficients in three solvent systems (1-octanol/ 0.1N NaOH,n-heptane/0.1N NaOH and toluene/0.1N NaOH), ionisation constants and thin-layer and reverse phase high pressure liquid chromatography retention data were determined for metoclopramide, its mono- and di-N-dealkylated metabolites, and for clebopride and its N-debenzylated metabolic product. Values for the additive-constitutive parameters , R m andx were calculated for the alkyl substituents at the basic centre of the two drugs, and the results are discussed.The relationship between these physico-chemical parameters and thein vivo membrane penetrating capacity (this capacity was determined using buccal absorption measurements) is discussed.



Metabolism of clebopride in vitro Identification of N -oxidized products

July 1980

·

9 Reads

·

3 Citations

Xenobiotica

1. N-(1'-Benzyl-4'-piperidyl-N-oxide)-4-amino-5-chloro-2-methoxybenzamide, N-(4'-(N-hydroxylpiperidyl)-4-amino-5-chloro-2-methoxybenzamide and N-(4'-(delta 1'-piperidyl-N-oxide))-4-amino-5-chloro-2-methoxybenzamide were obtained from chloroform extracts of incubation mixtures of clebopride or desbenzyl clebopride with 9000 g supernatant of liver homogenates of male NZW rabbits. 2. These metabolites were identified using electron impact (low and high resolution) and field desorption mass spectrometry, and computer averaged time proton magnetic resonance spectroscopy.


Metabolism of clebopride in vitro. Mass spectrometry and identification of products of amide hydrolysis and N -debenzylation

April 1980

·

13 Reads

·

9 Citations

Xenobiotica

1. Electron impact and field desorption mass spectrometry is described and discussed for clebopride, a newly developed benzamide with anti-emetic and anti-dopaminergic properties, and for some related compounds. 2. When clebopride was incubated with liver homogenates of rabbits, 4-amino-5-chloro-2-methoxybenzoic acid and N-(4'-piperidyl)-4-amino-5-chloro-2-methoxybenzamide were identified as metabolites.


Citations (51)


... The mass spectra of the condensation products exhibited base ions at m/z 57 (norephedrine) or 71 (ephedrine), and were consistent with formation of the corresponding oxazolidines as depicted in Fig. 2A. Both norephedrine [23] and ephedrine [24,25] are known to form oxazolidines upon reaction with formaldehyde. The net change in molecular weight for the oxazolidines relative to the unreacted amines is an increase of 12 units (M + 12), corresponding to the addition of the methylene group across the oxygen and amine moieties. ...

Reference:

Partial conversion of methanol to formaldehyde in the gas chromatography injection port and reactivity with amines
Identification and stereochemistry of (2S, 4S, 5R)- and (2R, 4S, 5R)-2,3,4-trimethyl-5-phenyloxazolidine, degradation products of ephedrine
  • Citing Article
  • December 1977

Chemischer Informationsdienst

... Oral Administration. The first report of (−)-MAMP pharmacology in humans was published in 1973 by Beckett et al. 23 In this work, the urinary pharmacokinetics of unchanged and metabolized (+)-MAMP and (−)-MAMP were considered alongside those of ethyl-, n-propyl-, and n-butyl-amphetamine. After oral administration of the study drug (12.45 mg of methamphetamine HCl), urine specimens were collected from participants (N = 6) every half hour for the first 4 h, hourly up to 12 h, with intervals increasing in duration up to 24 and 48 h. ...

The effect of N-alkyl chain length and stereochemistry on the absorption, metabolism and urinary excretion of N-alkylamphetamines in man
  • Citing Article
  • October 1973

Journal of Pharmacy and Pharmacology

... All reagents and solvents (HPLC grade) were commercial products of the highest available purity, and were used as supplied. (±)-N-methyl-α-methyl-dopamine hydrobromide was synthesized in four steps, from commercially available 3,4-dimethoxy-benzaldehyde and nitroethane, through procedures previously reported [32][33][34][35]. 5-(Glutathion-S-yl)-N-methyl-α-methyldopamine 1 and 5-(Nacetylcystein-S-yl)-N-methyl-α-methyldopamine 2 were synthesized through our recently reported one-pot electrochemical procedure [31]. ...

Synthesis of some N-oxygenated products of 3,4-dimethoxyampetamine and its N-alkyl derivatives
  • Citing Article
  • December 1975

Tetrahedron

... The metabolism of nitrogen-containing functional groups has become a topic of considerable interest since the early discovery that N-hydroxylated intermediates are often responsible for the toxic and/or carcinogenic properties of aromatic amines, hydrazines, and amides (1). On the other hand, the more facile N-oxygenation of secondary and tertiary alkylamines to hydroxylamines and N-oxides was considered as a route for detoxication (2,3), and it was generally assumed that the strongly basic nitrogen compounds were metabolically stable. However, we have demonstrated that even the protonated hydrophilic amidines (4 -6), as well as diamidines such as pentamidine and diminazene and also guanidines and amidinohydrazones, are capable of undergoing metabolic N-oxygenation by liver microsomal cytochrome P450 monooxygenases (7,8). ...

Metabolic N-Oxidation of Primary and Secondary Aliphatic Medicinal Amines
  • Citing Article
  • January 1977

Drug Metabolism Reviews

... 147 When nicotine N-oxide was orally administered to humans or rats, significant amounts of nicotine were excreted in the urine. 31,148 This was not observed after intravenous administration, 148 suggesting that the conversion of nicotine N-oxide to nicotine is mediated by intestinal tissues and/or gut contents. Indeed, rat intestine homogenates, as well as gut contents, were shown to catalyze nicotine N-oxide reduction under anaerobic conditions. ...

Reduction in vivo of (−)-nicotine-1′-N-oxide by germ-free and conventional rats
  • Citing Article
  • March 1975

Biochemical Pharmacology

... 1.6 mg/g. The resulting dosage per recommended serving matches roughly earlier reports concerning IPNS-containing tablets from 2014,6 where ca.20-40 mg per serving (tablet) was found in the context of follow-up investigations into serious adverse events. Urine samples collected after the ingestion of ca. ...

Synthesis of N-alkyl-N-hydroxyamphetamines and related nitrones
  • Citing Article
  • December 1973

Tetrahedron

... Indeed, rat intestine homogenates, as well as gut contents, were shown to catalyze nicotine N-oxide reduction under anaerobic conditions. 149 However, the oral administration of nicotine N-oxide to germ-free or antibiotics-treated rats led to urinary nicotine excretion to the extents similar to those in conventional or non-antibiotic-treated rats. 149 These results indicate that nicotine N-oxide reduction is mediated mainly by host enzymes and/or nonenzymatic processes, with a minimal contribution by the gut microbiota. ...

In vitro hepatic and extra-hepatic reduction of (−)-nicotine-1′-N-oxide in rats
  • Citing Article
  • January 1975

Biochemical Pharmacology

... In the first step, racemic 1-(10H-phenothiazin-10-yl)propan-2ol (±)-3 was synthesized according to the method described by Clement et al. [59], in which propylene oxide (2) was regiose-lectively opened by phenothiazine (1) in the presence of n-butyllithium (n-BuLi) at ambient temperature providing desired alcohol (±)-3 in 64-77% yield depending on the applied scale and the purification method (see Supporting Information File 1). Paradoxically, the product was obtained in higher yield when the reaction was performed on a bigger scale, and when the product was isolated by vacuum distillation instead of column chromatography (SiO 2 ). ...

Synthesis of Some Metabolites of Promethazine
  • Citing Article
  • January 1981

Archiv der Pharmazie

... Nonetheless, the urine sample of the athlete who ingested Mucaine 1 did not have phentermine as one of the metabolites, which was inconsistent with the pharmaceutical manufacturer's information [12]. Beckett and Bé langer reported that mephentermine can be metabolized in vivo by oxidative dealkylation to yield phentermine as its major metabolite [13]. The NOC searched unsuccessfully for an explanation for these extraordinary test phenomena of tests. ...

The identification and analysis of the metabolic products of mephentermine
  • Citing Article
  • January 1976

Journal of Pharmacy and Pharmacology

... Mammalian metabolism of N-alkylamphetamines is species dependent, and products formed in in vivo studies differ from those formed in vitro (8)(9)(10)(11). The supernatant fraction of rat liver homogenate converted NPA to six products (9), which were the results of C-oxidation (IIa, IIb, and IIIa) and N-oxidation (IVa, IVb, and V), but no p-hydroxylated products (Ib) were formed. In contrast, in vivo metabolism of NPA in rats (10) resulted in C-oxidation (Ib, IIb, and IIIa) but not N-oxidation. ...

In vitro metabolism of 1-phenyl-2-(n-propylamino) propane (N-propylamphetamine) by rat liver homogenates
  • Citing Article
  • December 1976

Journal of Pharmacy and Pharmacology